Novel bladder cancer treatment gains MHRA approval in the UK
Johnson & Johnson has announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorization for BALVERSA®▼ (erdafitinib) ...
Tag: Bladder Cancer
DNA repair gene mutations predict bladder cancer response to neoadjuvant chemotherapy
An analysis of pre-treatment tumor specimens from 105 patients with localized muscle-invasive bladder cancer found that the presence of a ...
Study unveils novel bladder cancer diagnostic model based on key mitochondrial genes
With millions of cases of bladder cancer (BC) around the world, the need for tools to ensure a timely diagnosis ...
BCG vaccine associated with reduced risk of Alzheimer's disease and related dementias
The Bacillus Calmette-Guérin (BCG) vaccine-;which prevents tuberculosis-;offers multiple beneficial effects, and it's currently a recommended therapy for non–muscle-invasive bladder cancer. ...
TTUHSC El Paso scientist receives $2.6 million NIH grant for research on tuberculosis
For over a century, El Paso has long been a sanctuary for individuals suffering from tuberculosis. It will soon be ...
Five teams awarded funding from the Starr Cancer Consortium to advance cancer research
Five teams led by Weill Cornell Medicine scientists have been awarded funding from the Starr Cancer Consortium in its 16th ...
UKB resident awarded the C. E. Alken Prize for outstanding scientific uro-oncological research
Dr. Niklas Klümper, resident at the Clinic for Urology and working group leader at the Institute for Experimental Oncology at ...
MSK researchers reveal a promising treatment option for bladder cancer patients
Researchers from Memorial Sloan Kettering Cancer Center (MSK) shared a promising treatment option for bladder cancer patients today at The ...
Research could lead to a new therapeutic option for patients with bladder cancer
Mount Sinai researchers have made two important discoveries about the mechanism by which bladder cancer cells foil attacks from the ...
Improving dialogue between healthcare professionals and patients in bladder cancer
In this interview with Dr. Ignacio Durán, who is a medical oncologist at Hospital Universitario Marqués de Valdecilla, and Alex ...
